Journal of Shandong University (Health Sciences) ›› 2025, Vol. 63 ›› Issue (1): 108-114.doi: 10.6040/j.issn.1671-7554.0.2024.0691
• Clinical Research • Previous Articles
AI Xiancheng, WANG Fei, ZHOU Wenzhong, YU Lixiang, ZHOU Fei, XIANG Yujuan, LI Liang, YU Zhigang
CLC Number:
[1] Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249. [2] 乔江华, 刘真真. 多学科综合治疗助力乳腺癌质量控制规范化[J]. 肿瘤综合治疗电子杂志, 2023, 9(3): 19-22. QIAO Jianghua, LIU Zhenzhen. Multidisciplinary team improve the quality control of breast cancer diagnosis and treatment[J]. Journal of Multidisciplinary Cancer Management(Electronic Version), 2023, 9(3): 19-22. [3] 刘真真. 《河南省肿瘤诊疗质量控制中心乳腺癌专家委员会专家共识》序言[J]. 中华肿瘤防治杂志, 2023, 30(24): 1459-1460. LIU Zhenzhen. Preface to expert consensus of breast cancer expert committee in Henan cancer diagnostic and treatment quality control center[J]. Chinese Journal of Cancer Prevention and Treatment, 2023, 30(24): 1459-1460. [4] 孙湛, 杨丽, 邵雨婷, 等. 多学科诊疗模式现状分析与思考[J]. 中国卫生质量管理, 2018, 25(6): 37-40. SUN Zhan, YANG Li, SHAO Yuting, et al. Analysis and thinking on the current situation of multidisciplinary diagnosis and treatment mode[J]. Chinese Health Quality Management, 2018, 25(6): 37-40. [5] 胡夕春, 王磊苹. 2012年ASCO年会乳腺癌热点报道[J]. 中华乳腺病杂志(电子版), 2012, 6(4): 351-357. HU Xichun, WANG Leiping. Hot report on breast cancer in 2012 ASCO annual meeting[J]. Chinese Journal of Breast Disease(Electronic Edition), 2012, 6(4): 351-357. [6] 王丹, 莫陶欣, 薛冬, 等. 首批国家肿瘤多学科诊疗试点医院情况分析[J]. 中国肿瘤, 2021, 30(5): 352-356. WANG Dan, MO Taoxin, XUE Dong, et al. Operational status of the first batch of national pilot Units of cancer multidisciplinary team for the diagnosis and treatment[J]. China Cancer, 2021, 30(5): 352-356. [7] 杨凌鹤, 刘美岑, 曹曼, 等. 我国三级肿瘤医院多学科诊疗模式开展现状调查[J].中国卫生质量管理, 2022, 29(10): 40-44. YANG Linghe, LIU Meicen, CAO Man, et al. Multi-disciplinary team model in Chinas tertiary tumor hospitals: a cross-sectional investigation[J]. Chinese Health Quality Management, 2022, 29(10): 40-44. [8] 中华人民共和国国家卫生和计划生育委员会. 关于加强肿瘤规范化诊疗管理工作的通知[EB/OL].(2016-09-28)[2024-06-30]. http://www.nhc.gov.cn/bgt/2016dsq/201609/0578f2ecbdd54e96a204bb2479b89a5f.shtml. [9] 中华人民共和国国家卫生和计划生育委员会,国家中医药管理局.关于印发进一步改善医疗服务行动计划(2018—2020年)的通知[EB/OL].(2017-12-29)[2024-06-30]. https://www.gov.cn/gongbao/content/2018/content_5299607.htm. [10] Fleissig A, Jenkins V, Catt S, et al. Multidisciplinary teams in cancer care: are they effective in the UK?[J]. Lancet Oncol, 2006, 7(11): 935-943. [11] Friedman EL, Chawla N, Morris PT, et al. Assessing the development of multidisciplinary care: experience of the national cancer institute community cancer centers program[J]. J Oncol Pract, 2015, 11(1): e36-e43. [12] Korde LA, Somerfield MR, Carey LA, et al. Neoadjuvant chemotherapy, endocrine therapy, and targeted therapy for breast cancer: ASCO guideline[J]. J Clin Oncol, 2021, 39(13): 1485-1505. [13] 郝婧灿, 何幡, 李娜, 等. 综合医院肿瘤多学科诊疗质量管理的现状及分析[J]. 现代医院管理, 2022, 20(4): 28-31. HAO Jingcan, HE Fan, LI Na, et al. Status quo and analysis of quality management of multidisciplinary diagnosis and treatment for tumors in comprehensive hospitals[J]. Modern Hospital Management, 2022, 20(4): 28-31. [14] 余松轩, 赵蓉, 李贤华, 等. 上海市医院多学科诊疗模式标准研制与思考[J]. 中国卫生质量管理, 2021, 28(12): 14-17. YU Songxuan, ZHAO Rong, LI Xianhua, et al. Development and consideration of multi-disciplinary treatment mode standard in hospitals in Shanghai[J]. Chinese Health Quality Management, 2021, 28(12): 14-17. [15] 林芸, 谢燕秋. 乳腺癌患者生育力保护及保存[J]. 山东大学学报(医学版), 2022, 60(9): 42-46. LIN Yun, XIE Yanqiu. Fertility protection and preservation in breast cancer patients[J]. Journal of Shandong University(Health Sciences), 2022, 60(9): 42-46. [16] Ueno NT, Ito TD, Grigsby RK, et al. ABC conceptual model of effective multidisciplinary cancer care[J]. Nat Rev Clin Oncol, 2010, 7(9): 544-547. [17] Capobianco AML, Gallucci G, Lapadula L, et al. Impact of the multidisciplinary cancer team on the diagnostic and therapeutic care pathway of early breast cancer patients and perception of team members: the experience of a cancer centre in Italy[J]. Cancer Invest, 2024, 42(1): 12-20. [18] Pangarsa EA, Rizky D, Tandarto K, et al. The effect of multidisciplinary team on survival rates of women with breast cancer: a systematic review and meta-analysis[J]. Ann Med Surg, 2023, 85(6): 2940-2948. [19] 辛灵, 向泓雨, 叶京明, 等. 《肿瘤专业医疗质量控制指标(2023年版)》与乳腺外科热点问题[J]. 中华外科杂志, 2024, 62(2): 93-98. XIN Ling, XIANG Hongyu, YE Jingming, et al. Quality Control Indexes for Oncology(2023 edition)and hot topics in breast surgery[J]. Chinese Journal of Surgery, 2024, 62(2): 93-98. [20] 孟利伟, 楼亦锜, 章蔚, 等. 多学科诊疗模式对乳腺癌术后辅助化疗决策的影响及相关因素分析[J]. 中华内分泌外科杂志, 2019, 13(5): 408-412. MENG Liwei, LOU Yiqi, ZHANG Wei, et al. The influence of multidisciplinary team on adjuvant chemotherapy for postoperative breast cancer patients[J]. Chinese Journal of Endocrine Surgery, 2019, 13(5): 408-412. [21] 周亚杰, 王斐, 于理想, 等. 女性乳腺癌保乳手术决策相关因素[J]. 山东大学学报(医学版), 2022, 60(12): 1-6. ZHOU Yajie, WANG Fei, YU Lixiang, et al. Factors related to decision-making of breast-conserving surgery for female breast cancer[J]. Journal of Shandong University(Health Sciences), 2022, 60(12): 1-6. [22] 沈坤炜, 李宏为. 乳腺癌的现代治疗模式:多学科综合诊治[J]. 外科理论与实践, 2014, 19(5): 369-371. SHEN Kunwei, LI Hongwei. Modern treatment model of breast cancer: multidisciplinary comprehensive diagnosis and treatment[J]. Journal of Surgery Concepts & Practice, 2014, 19(5): 369-371. [23] Baldwin LM, Taplin SH, Friedman H, et al. Access to multidisciplinary cancer care: is it linked to the use of breast-conserving surgery with radiation for early-stage breast carcinoma?[J]. Cancer, 2004, 100(4): 701-709. [24] Chan WF, Cheung PS, Epstein RJ, et al. Multidisciplinary approach to the management of breast cancer in Hong Kong[J]. World J Surg, 2006, 30(12): 2095-2100. [25] 国家肿瘤质控中心乳腺癌专家委员会. 中国乳腺癌规范诊疗质量控制指标(2022版)[J]. 中华肿瘤杂志, 2022, 44(3): 203-208. Breast Cancer Expert Committee of National Cancer Quality Control Center. Quality control index for standardized diagnosis and treatment of breast cancer in China(2022 Edition)[J]. Chinese Journal of Oncology, 2022, 44(3): 203-208. [26] 郭晓培, 王平. 北京某医院医患双方对MDT诊疗模式的认知调查[J]. 医院管理论坛, 2021, 38(3): 42-46. GUO Xiaopei, WANG Ping. Investigation on cognition of MDT diagnosis and treatment model in doctors and patients in a Beijing hospital[J]. Hospital Management Forum, 2021, 38(3): 42-46. [27] Saini KS, Taylor C, Ramirez AJ, et al. Role of the multidisciplinary team in breast cancer management: results from a large international survey involving 39 countries[J]. Ann Oncol, 2012, 23(4): 853-859. [28] 杨凌鹤, 温中一, 刘美岑, 等. 我国40家三级公立医院多学科诊疗模式经验总结[J]. 中华医院管理杂志, 2021, 37(6): 505-508. YANG Linghe, WEN Zhongyi, LIU Meicen, et al. Experience of multi-disciplinary team mode in 40 tertiary public hospitals in China[J]. Chinese Journal of Hospital Administration, 2021, 37(6): 505-508. [29] 赋能专科建设—共创健康中国多学科专家委员会,中国抗癌协会乳腺癌专业委员会. 乳腺癌多学科诊疗标准与规范(2023年版)[J]. 中国癌症杂志, 2023, 33(12): 1188-1203. Energizing Specialty Construction-Multidisciplinary Expert Committee for Creating Healthy China, The Society of Breast Cancer China Anti-Cancer Association. Standardization of multi disciplinary team treatment for breast cancer(2023 edition)[J]. China Oncology, 2023, 33(12): 1188-1203. [30] 王佳妮, 欧开萍, 刘嘉琦, 等. 乳腺癌多学科综合诊疗模式的能力建设及发展趋势[J]. 中国普通外科杂志, 2023, 32(5): 656-664. WANG Jiani, OU Kaiping, LIU Jiaqi, et al. Capacity building and development trends of the multidisciplinary integrated treatment model for breast cancer[J]. Chinese Journal of General Surgery, 2023, 32(5): 656-664. |
[1] | WANG Wei, WANG Yi-Feng, ZHANG Ling-Mei, LIN Qiong-Yan, HUANG Ju. umorigenicity and invasion of side population in human ovarian epithelial cancer OVCAR3 cells [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2209, 47(6): 8-11. |
[2] | LI Bo-Bo, LI Dao-Tang, LIU Shu-Guang, WANG Xing-Wu. Expression of serum DKK-1 in esophageal cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2209, 47(6): 58-61. |
[3] | YU Zhigang, ZHENG Chao. Current status, challenges and innovative approaches of multidisciplinary treatment for breast cancer [J]. Journal of Shandong University (Health Sciences), 2025, 63(1): 1-9. |
[4] | . Shandong Province expert consensus on multidisciplinary treatment of breast cancer(2024 edition) [J]. Journal of Shandong University (Health Sciences), 2025, 63(1): 10-16. |
[5] | CHENG Yueqi, WANG Fei, YU Lixiang, ZHENG Chao, YU Zhigang. Progress in the study of trastuzumab-induced cardiotoxicity in HER2-positive breast cancer patients [J]. Journal of Shandong University (Health Sciences), 2025, 63(1): 17-24. |
[6] | WANG Min, LI Xiping, TAN Jun, QIU Mei, HOU Zeyu, TIAN Ying, LUO Hongying, FAN Chaowen, QI Ling, YU Qi, XIE Wei. Lentivirus vector-mediated Gag-Caspase-8 induces apoptosis and S-phase arrest in triple-negative breast cancer primary cells [J]. Journal of Shandong University (Health Sciences), 2025, 63(1): 25-34. |
[7] | ZHANG Jie, ZHANG Fangfang, WANG Jingnan, LI Zeyu, SONG Ying, LI Na. Expression of circ_0000144 in breast cancer and its effect on the proliferation, migration and invasion ability of breast cancer cells [J]. Journal of Shandong University (Health Sciences), 2025, 63(1): 35-42. |
[8] | SONG Yawen, GUO Liantao, KONG Deguang, SUN Shengrong. VTCN1 causes poor prognosis and endocrine therapy resistance in HR+ breast cancer [J]. Journal of Shandong University (Health Sciences), 2025, 63(1): 43-59. |
[9] | LIU Jingjing, PANG Jing, ZHAO Xiaodan, LIN Xin, FU Min, CHEN Jingjing. Machine learning model based on mammography and DCE-MRI to predict pathological complete response after neoadjuvant therapy in breast cancer: a dual center research [J]. Journal of Shandong University (Health Sciences), 2025, 63(1): 60-72. |
[10] | SUN Jing, YANG Ruimin, WANG Cong, ZHANG Yue, LUO Bing. Combined models based on preoperative ultrasound, inflammatory indicators and ultrasound radiomics for predicting axillary lymph node metastasis of breast cancer [J]. Journal of Shandong University (Health Sciences), 2025, 63(1): 73-80. |
[11] | LI Yong, CUI Shujun, YANG Fei, ZHANG Fan, YIN Xiaoxia. Enhanced MRI-based subregional radiomics model can predict pathological complete response after neoadjuvant chemotherapy in breast cancer patients [J]. Journal of Shandong University (Health Sciences), 2025, 63(1): 81-89. |
[12] | LU Xiaosong, YANG Ruimin, WANG Yicheng, ZHOU Haifeng, LUO Bing, LI Xiaoyu, LI Nana. Clinical value of ultrasound radiomics based on peritumour-containing tissues in identifying benign and malignant breast nodules [J]. Journal of Shandong University (Health Sciences), 2025, 63(1): 90-98. |
[13] | YUAN Zonghuai, PAN Guangye, CHI Yuemei, AN Chuanguo, ZHANG Yonggang. Causal relationship between low grade serous ovarian cancer and breast cancer analyzed by Mendelian randomization [J]. Journal of Shandong University (Health Sciences), 2025, 63(1): 99-107. |
[14] | LIU Xiangrong, ZHANG Xinsheng, YANG Jinran, YANG Xueyan, LIU Zhao, LIU Yinghua. Association of the ratio of ω-6/ω-3 polyunsaturated fatty acids with various tumor types risk: a systematic review and Meta-analysis [J]. Journal of Shandong University (Health Sciences), 2024, 62(8): 34-48. |
[15] | ZHANG Xinrui, SUN Peng, LI Feng. Trajectory analysis of post-craniotomy headache in brain tumor patients based on growth mixture modeling [J]. Journal of Shandong University (Health Sciences), 2024, 62(6): 102-107. |
Viewed | ||||||||||||||||||||||||||||||||||||||||||||||||||
Full text 35
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||
Abstract 127
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||
Cited |
|
|||||||||||||||||||||||||||||||||||||||||||||||||
Shared | ||||||||||||||||||||||||||||||||||||||||||||||||||
Discussed |
|